DONATE

Search Results for:

An unprecedented mutation map reveals how amylin mutations influence type 2 diabetes

A study by the Institute for Bioengineering of Catalonia (IBEC) has created a mutational map of the hormone amylin, the aggregation of which can damage pancreatic cells and lead to type 2 diabetes. The team analysed 1,916 variants of the protein and compared the results of this mutational map with genetic and clinical data from 500,000 individuals. The study, published in Nature Communications, sheds new light on the role of genetics in diabetes and could lead to the development of safer and more effective drugs.

A new generation of therapeutic nanorobots set to transform the medicine of the future

Samuel Sánchez

Research carried out at IBEC by Samuel Sánchez and his team has led to the development of a new generation of therapeutic nanorobots. These nanorobots can move through the body, reach tumours and deliver drugs with great precision. These nanorobots have already reduced bladder tumours by up to 90% in preclinical models and are being investigated for use in treating other diseases. They were presented to the public at MWC26 through an immersive experience demonstrating how this technology could transform future treatments.

Ibec Seminar: Dr Pascale Quilichini

Neuronal infra-slow rhythm in the thalamic nucleus reuniens orchestrate hippocampo-prefrontal information flow during sleep Dr Pascale Quilichini, Institut de Neurosciences des Systèmes, INSERM, Aix-Marseille University The consolidation of episodic memory … Read more

Research4talent

The event offers you the opportunity to engage with our researchers and inquire about their day-to-day work in the lab, career trajectories, work-life balance, mobility, etc. In 2025, IBEC signed … Read more

Ibec Seminar: Dr. Federico Fenaroli

Developing Nanomedicines Using the Zebrafish Embryo Dr. Federico Fenaroli,  University of Stavanger, Norwey Our research focuses on the development of nanomedicines to combat bacterial infections and cancer. We investigate the … Read more

IBEC participates in the first Workplace Travel Plan launched by the Barcelona Science Park to promote more sustainable mobility

The University of Barcelona Science Park (PCB-UB) has launched its first Workplace Travel Plan (PDE), a joint initiative by the Institute for Bioengineering of Catalonia (IBEC), the Institute for Research in Biomedicine (IRB Barcelona), Biocat, the Scientific and Technological Centers of the UB (CCiTUB), and the PCB itself, aimed at improving commuting mobility and reducing the environmental impact of daily travel.